ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.102164T>C (p.Val34055Ala)

gnomAD frequency: 0.00001  dbSNP: rs752582515
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV001546027 SCV001765469 likely benign not provided 2020-03-17 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV002282561 SCV002572420 likely benign not specified 2022-08-29 criteria provided, single submitter clinical testing Variant summary: TTN c.94460T>C (p.Val31487Ala) results in a non-conservative amino acid change located in the M-band region of the encoded protein sequence. Three of four in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00014 in 248340 control chromosomes, predominantly at a frequency of 0.00099 within the Latino subpopulation in the gnomAD database. The observed variant frequency within Latino control individuals in the gnomAD database is approximately 2.5-fold of the estimated maximal expected allele frequency for a pathogenic variant in TTN causing Dilated Cardiomyopathy phenotype (0.00039), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Latino origin. c.94460T>C has been reported in the literature in an individual affected with polymicrogyria (Allen_2021). This individual also had a de novo co-occurrence classified as pathogenic by the authors (CCND2 p.Thr280Asp). This report does not provide unequivocal conclusions about association of the variant with Dilated Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as likely benign.
Revvity Omics, Revvity RCV001546027 SCV003820296 uncertain significance not provided 2022-06-13 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.